Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Publication
Article
Pharmacy Times
Volume00
Update on Investigational Alzheimer's Drug
Author(s):
Voyager Pharmaceutical Corp recently informed its shareholders of preliminary results from a trial of an investigational drug to treat Alzheimer's disease (AD). The researchers studying the drug, Memryte, observed positive effects among women but not among men.
The findings have prompted Voyager to focus on developing the drug to treat AD specifically for women.
Articles in this issue
pharmacy TECHNOLOGY news
pharmacy TECHNOLOGY products
health-systems PRODUCT news
generic times product news
can you READ these Rxs?
A closer look at new FDA actions
can you READ these Rxs?
compounding HOTLINE
Is There Science in Quality?
Vaccines: Are You Protected?
Rodden Selected as Wal-Mart Pharmacy District Manager of the Year
Community Pharmacy Works to Preserve Choice for Military
Pharmacy Crime Watch Reduces Robbery and Rx Fraud
Sunburn Products
caseSTUDIES
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Content
